Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Enovis Corp

C520
Current price
37.8 EUR 0 EUR (0.00%)
Last closed 41.27 USD
ISIN US1940145022
Sector Industrials
Industry Specialty Industrial Machinery
Exchange Frankfurt Exchange
Capitalization 2 233 461 504 USD
Yield for 12 month -9.76 %
1Y
3Y
5Y
10Y
15Y
C520
21.11.2021 - 28.11.2021

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators management, and physical therapy products which are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals. The company's Reconstructive segment operates surgical implant business, which includes a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger, as well as surgical productivity tools. The company distributes its products through independent distributors and directly under the ESAB and DJO brands. Enovis Corporation was formerly known as Colfax Corporation. The company was founded in 1995 and is headquartered in Wilmington, Delaware. Address: 2711 Centerville Road, Wilmington, DE, United States, 19808

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

67.22 USD

P/E ratio

Dividend Yield

Current Year

+1 707 197 000 USD

Last Year

+1 563 101 000 USD

Current Quarter

+525 159 999 USD

Last Quarter

+516 266 000 USD

Current Year

+990 779 000 USD

Last Year

+869 383 000 USD

Current Quarter

+247 946 999 USD

Last Quarter

+297 896 000 USD

Key Figures C520

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 243 691 008 USD
Operating Margin TTM -2.99 %
PE Ratio
Return On Assets TTM -0.1 %
PEG Ratio 1.8989
Return On Equity TTM -3.17 %
Wall Street Target Price 67.22 USD
Revenue TTM 1 913 970 048 USD
Book Value 59.9 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 22.6 %
Dividend Yield
Gross Profit TTM 883 885 000 USD
Earnings per share -1.95 USD
Diluted Eps TTM -1.95 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 153.1 %
Profit Margin -4.73 %

Dividend Analytics C520

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History C520

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 581:1000
Payout Ratio
Last Split Date 05.04.2022
Dividend Date

Stock Valuation C520

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 13.1579
Enterprise Value Revenue 1.8891
Price Sales TTM 1.1669
Enterprise Value EBITDA 20.8063
Price Book MRQ 0.6796

Financials C520

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators C520

For 52 weeks

38.27 USD 65.03 USD
50 Day MA 42.53 USD
Shares Short Prior Month 4 240 509
200 Day MA 50.68 USD
Short Ratio 6.34
Shares Short 4 435 072
Short Percent 9.09 %